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Introduction
Neuroscience presents important neuro-
ethical considerations. Human neurosci-
ence demands focused application of the
core research ethics guidelines set out in
documents such as the Belmont Report.
Various mechanisms, including institu-
tional review boards (IRBs), privacy rules,
and the Food and Drug Administration,
regulate many aspects of neuroscience
research and many articles, books, work-
shops, and conferences address neuroeth-
ics. (Farah, 2010; https://bioethicsarchive.
georgetown.edu/pcsbi/studies.html; http://
www.neuroethicssociety.org/annual-
meeting). However, responsible neurosci-
ence research requires continual dialogue
among neuroscience researchers, ethicists,
philosophers, lawyers, and other stakehold-
ers to help assess its ethical, legal, and
societal implications. The Neuroethics
Working Group of the National Institutes
of Health (NIH) Brain Research through
Advancing Innovative Neurotechnologies
(BRAIN) Initiative, a group of experts pro-
vidingneuroethics input to theNIHBRAIN
Initiative Multi-Council Working Group,
seeks to promote this dialogue by pro-
posing the following Neuroethics Guid-
ing Principles (Table 1).
Two general points frame these princi-
ples. First, pursuing neuroscience re-
search is an ethical imperative. Brain
diseases and disorders cause immense suf-
fering and have a major economic impact
worldwide. Our ability to intervene med-
ically is hampered by limited understand-
ing of brain function and of how brain
circuits go awry in disorders such as
dementia, chronic pain, depression, ad-
diction, and autism. The NIH BRAIN Ini-
tiative focuses on developing new tools
and neurotechnologies to transform un-
derstanding of brain function in health
and disease. That knowledge is critical to
enabling novel therapies for brain disor-
ders and thus is ethically compelled.
Second, neuroethics is vital to neuro-
science research. The consideration of
ethical, legal, and societal implications of
neuroscience research facilitates prog-
ress in neuroscience and helps to ensure
that neuroscientific advancements sup-
port human well-being. Integrating neu-
roethics into the NIH BRAIN Initiative
serves the interests of all involved stake-
holders. Success requires collaborative in-
put from many disciplines, including
neuroscience,medicine, bioethics, philos-
ophy, law, and others.
We intend these principles to serve
as points to consider for researchers,
IRBs, and others involved in the con-
duct of BRAIN-funded research. They
also may be useful to NIH leadership
and advisory groups when considering fu-
ture research directions (http://doi.org/
10.1523/JNEUROSCI.2091-18.2018) and
likely to people and groups beyond the
NIH BRAIN Initiative.
Neuroethics Guiding Principles
1. Make assessing safety paramount
Human subjects protections place the
highest priority on research participant
safety, including physical, psychological,
and emotional consequences of research
participation, in the short, intermediate,
and long term. This is particularly impor-
tant in neuroscience research because the
complexity of the human brain lends un-
predictability to outcomes of intervention
and may heighten the likelihood and
potential severity of unexpected conse-
quences, including those emerging at later
times because of the brain’s plasticity.
Safety also is crucial when implementing
interventions for widespread clinical use
in treating brain diseases and disorders.
Safety can never be guaranteed, but risks
must be rigorously assessed and carefully
weighed against likely benefits in both re-
search and treatment. The development
of safe interventions depends on robust
experimental design throughout the re-
search pipeline, including adherence to
the highest standards for rigor and repro-
ducibility. Early-stage research with non-
human model systems must be carefully
designed to identify potential limitations
during translational phases of research.
For example, new methods of neuro-
modulation (invasive or otherwise) may
create unanticipated interactions and re-
verberating consequences. New gene-
editing technologies such as CRISPR/
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CAS, while offering hope formitigating or
eliminating brain disorders, are still in
their infancy and carry potential for off-
target effects. It is essential to attend to
safety data from preclinical studies and to
monitor safety throughout research when
evaluating such innovative approaches for
potential efficacy in humans. Research
participants must be thoroughly informed
of potential risks and benefits, as well as the
possibility of unexpected safety issues.
2. Anticipate special issues related to
capacity, autonomy, and agency
Contemporary neuroscience research may
enable greater understanding of brain
disorders associated with impaired, fluctu-
ating, or diminished decision-making ca-
pacities and diminished agency (our ability
to choose our actions) and autonomy (our
ability to freely make informed choices).
Someof these disordersmaypresent in chil-
dren, in whom these characteristics are also
limited. Responsible BRAIN-funded re-
search must study, not only “competent”
and autonomous adults, but also people
with diminished or developing autonomy
and decision-making capacity. The chal-
lenges of a fair consent process that allows
participation of those with limited, “dif-
ferent,” or fluctuating capacity to consent
are not new but require constant atten-
tion. For example, in research with pa-
tients with Alzheimer’s dementia, routine
assessment of how well participants re-
ceive and process information and their
decision-making ability is crucial. This
may prove especially challenging for pa-
tient participants with advanced forms of
the disease or when research involves in-
novative techniques that may perturb ca-
pacity in ways unfamiliar to participants.
Some interventions may lead to unan-
ticipated changes in preferences and
agency, as in reported personality changes
after deep-brain stimulation for move-
ment disorders (Lewis et al., 2015). In
contrast, patients with neuropsychiatric
conditions may actively seek such altera-
tions to enhance their agency or restore
capacities. Researchers may find them-
selves in the paradoxical position of seek-
ing informed consent from participants
while at the same time manipulating neu-
ral processes necessary for consent capac-
ity and autonomous choice. For example,
brain stimulation paradigms may target
circuits involved in reward processing and
motivation. Given our limited under-
standing of whether excessive stimulation
might undermine patient participants’ fu-
ture decision making, how much control
regarding stimulation parameters should
go to participants in alignment with their
autonomy interests rather than to re-
searchers? Researchers should be particu-
larly cautious to preserve and monitor
research participants’ ability to consent,
including consent to continued participa-
tion in research.
Providing participants with accurate,
easy to understand, and evidence-based
information about potential risks and
benefits will promote well informed deci-
sions about participation in neuroscience
research (https://www.accessdata.fda.gov/
scripts/cdrh/cfdocs/cfCFR/CFRSearch.
cfm?fr50.25). Care must be taken to
avoid overpromising to possible partic-
ipants, who may be desperate for a help-
ful intervention, and to discourage them
from believing that personal benefits are
more likely than they are.
3. Protect the privacy and
confidentiality of neural data
Research participants have a reasonable
expectation of privacy regarding their
neural data and that data’s interpretation,
which might include perceptions, emo-
tions, memories, and thoughts. NIH
BRAIN Initiative research is developing
bettermethods tomeasure brain structure
and activity. These data will be stored for
analysis and shared often with other re-
searchers with appropriate privacy pro-
tections to advance efforts to understand
the brain. Neural data should be treated as
private, sensitive information; its collec-
tion, transmission, and storage should ad-
here to best practices for security and
encryption. Conflicts may exist between
privacy/confidentiality and data sharing.
For example, large, shared databases con-
taining brain imaging data may be ex-
tremely useful for researchers studying
both healthy and atypical brain function-
ing, but every brain is unique and some-
day a brainMRImight be as identifying as
a fingerprint. A person with access to a
shared database, as well as an individual’s
MRI, might be able to determine whether
the individual was in the database and, if
so, obtain personal information about
him or her from the “de-identified”
database.
It is important that researchers and
policymakers find ways to manage these
problems. Research participants’ confi-
dentiality cannot be guaranteed both be-
cause of the risks of unauthorized release
of identified data through hacking and the
possibilities of re-identification. Research
participants must be given clear informa-
tion about these issues and an honest
chance to decide whether to accept the
risks.
4. Attend to possible malign uses of
neuroscience tools
and neurotechnologies
Novel tools and technologies, including
neurotechnologies, can be used both for
good ends and bad. Researchers should be
mindful of possible misuses that might
range from intrusive surveillance of brain
states to efforts to incapacitate or imper-
missibly alter a person’s behavior. Re-
searchers have a responsibility to try to
predict plausible misuses and ensure that
foreseeable risks are understood, as ap-
propriate, by research participants, IRBs,
ethicists, and government officials. When
possible, misuse should be prevented, for
example, through design of the technol-
ogy, such as ensuring secure wireless de-
vice connections.
5. Move neuroscience tools and
neurotechnologies into medical or
nonmedical uses with caution
BRAIN Initiative research includes cutt-
ing-edge science and first-in-human appli-
cations of novel neurotechnologies.
Accordingly, the likelihood of individual
benefit may be low and uncertain and
risks could be significant. Researchers
must thoroughly identify and minimize
potential research risks. A thoughtful jus-
tification of risks based on the potential
benefits is essential.
Hopes for neuroscience extend be-
yond research into exciting prospects for
novel therapeutics. In addition to safety,
researchers should consider questions of
efficacy and equity before novel neuro-
technologies becomewidely available. Re-
searchers and others involved in the NIH
BRAIN Initiative should discourage the
premature widespread use or inappropri-
ate adoption of new technologies, espe-
cially those that may be offered directly to
consumers or in non-health-care settings,
such as in the legal system. For example,
Table 1. Neuroethics Guiding Principles
1. Make assessing safety paramount
2. Anticipate special issues related to capacity, autonomy,
and agency
3. Protect the privacy and confidentiality of neural data
4. Attend to possible malign uses of neuroscience tools and
neurotechnologies
5. Move neuroscience tools and neurotechnologies into
medical or nonmedical uses with caution
6. Identify and address specific concerns of the public
about the brain
7. Encourage public education and dialogue
8. Behave justly and share the benefits of neuroscience
research and resulting technologies
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researchers looking for neural markers of
deception or pain should be aware that
segments of society may be eager to use
such tools for non-health-related ends.
Premature adoption of such tools before
accuracy is known is not appropriate.
6. Identify and address specific
concerns of the public about the brain
People care deeply about their minds and
brains and have concerns that researchers
may not sufficiently recognize. Even sci-
entifically unjustified fears can have im-
portant consequences for public response
to neuroscience work. Although sensitiv-
ity about brain-related issues varies be-
tween cultures, three examples follow.
Fear of mental invasion reaches far
back into human history, as does the idea
of cognitive liberty—that the freedomand
privacy of one’s mind (and thus brain) is
sacrosanct. Some might have concerns
that a beneficial improvement in ability to
control the dysfunctional mind (e.g.,
from memory loss or seizures) also may
have detrimental outcomes and poten-
tially threatens cognitive liberty (Ienca
and Andorno, 2017). Second, many peo-
ple perceive their identity as being within
their brain. Novel neurointerventions
might disrupt that identity; for example,
brain implants might alter a persons’
sense of self or change their behavior in
unexpected or unwelcome ways (Gilbert
et al., 2017). Researchers should be aware
of these justified concerns that research
could “make a person someone else.” Last,
many consider the humanmind andbrain
to be distinguishing, perhaps definitive,
features of being human. Research with
human/nonhuman brain chimeras, neu-
ral organoids, and ex vivo human brain
tissue can provoke intellectual, visceral,
and moral concerns, including concerns
about the potential development of mor-
ally significant features in these tissues.
Researchers, funders, and others should
try to identify issues arising from their re-
search that the public might find sensitive,
taking into account the possibility of sensa-
tionalized media reports. Both the public
and researchers will benefit if the latter con-
sider public concerns when planning, im-
plementing, and discussing research, as
described in the next principle.
7. Encourage public education
and dialogue
Public trust in science is a precious com-
modity. To the greatest extent possible,
researchers should build—and retain—
that trust by keeping the public informed.
Public dialogue should be bidirectional,
where researchers stay abreast of the pub-
lic’s desires, concerns, and degree of
knowledge. Some conflicts between in-
forming the public about research as it
proceeds and researchers’ appropriate de-
sires to delay sharing preliminary findings
before appropriate review may be un-
avoidable. Nevertheless, transparency is
crucial, particularly with potentially con-
troversial research, to avoid unduly con-
cerning the public. Being a scientist today
requires not only good work, but also
good communication about that work.
Modern society offers scientists a wide ar-
ray of ways to communicate beyond the
traditional peer-reviewed paper and aca-
demic conference talk. Good ethical stew-
ardship of one’s work calls on scientists to
findmethods that best suit them, whether
through public talks, online scholarship,
creating social media content, giving in-
terviews, or other paths. Researchers have
an obligation to share knowledge both
about the brain and about where we con-
tinue to be ignorant about the brain’s
workings, alongwith possible benefits and
risks of research. University and govern-
ment communications offices also have
a critical role to play in promoting
transparency.
Hyperbole is in part driven by the
imaginations of scientists, the public, and
neuroethicists and because hype about
the next great breakthrough is widely
used to hold attention. Researchers,
science journalists, communications of-
fices, and others—including neuroethi-
cists—have essential roles to play in
promoting appropriate understanding,
avoiding hyperbole, and correcting
overly optimistic interpretations.
8. Behave justly and share the benefits
of neuroscience research and
resulting technologies
The former Presidential Commission for
the Study of Bioethical Issues wrote “. . . a
fundamental principle of fairness suggests
that society should seek to assure that the
benefits and burdens of new technolog-
ies are shared” (https://bioethicsarchive.
georgetown.edu/pcsbi/sites/default/
files/PCSBI-Synthetic-Biology-Report-
12.16.10_0.pdf). Early BRAIN Initiative
studies are likely to be small and fairness
in selection of research participants is
critical because more people may want
to participate than can be included
given finite opportunities and partici-
pants with few options for treatment
may be more open to untested options.
For example, experiments testing visual
prostheses may be very appealing to per-
sons severely affected by vision loss.
Similarly, the possible appeal of brain–
machine interface experiments for those
suffering from tetraplegia warrants
careful processes for selecting early trial
participants.
As technologies are found to be safe
and effective and enter clinical use, atten-
tion to widespread sharing of the benefits
of those technologies and interventions
will become a priority. Limited access to
safe and effective neural technologies
should not exacerbate existing health dis-
parities or inequalities, but neither should
the burdens of research fall dispropor-
tionately on those who lack access to es-
tablished interventions.
Conclusion
We offer these principles as points to
consider to help researchers and other
stakeholders better navigate the difficult
questions that the NIH BRAIN Initiative
research will pose to society. Neurosci-
ence research holds great promise. With
that promise comes great responsibility
for diverse stakeholders to ensure both
that the promise can be fulfilled and that it
is not distorted. Neuroethics can help to
achieve this goal through published dis-
cussions, research, consultation on com-
plex ethical issues arising from research,
the application of principles like those
herein.
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